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Abstract. The ryanodine receptor/junctional channel
complex (JCC) forms the calcium release channel and
foot structures of the sarcoplasmic reticulum. The JCC
and the dihydropyridine (DHP) receptor in the trans-
verse tubule are two of the major components involved
in excitation-contraction (E-C) coupling in skeletal
muscle. The DHP receptor is believed to serve as the
voltage sensor in E-C coupling. Both the JCC and
DHP receptor, as well as many skeletal muscle-specific
contractile protein genes, are expressed in the BC3H1
muscle cell line. In the present study, we find that dur-
ing differentiation of BC3H1 cells, induced by mitogen
withdrawal, induction of the JCC and DHP receptor
mRNAs is temporally similar to that of the skeletal
muscle contractile protein genes a-tropomyosin and
a-actin. Our data suggest that there is coordinate reg-
N striated muscle, depolarization of the sarcolemma is
coupled to the release of intracellular calcium from the
sarcoplasmic reticulum (SR).' This coupling takes place
across the triad junction, the intracellular junction between
the transverse tubule and the terminal cisternae of the SR,
joined by way of foot structures (Franzini-Armstrong and
Nunzi, 1983). In the past several years, major progress has
been made in the field of excitation-contraction (E-C) coup-
ling (Fleischer and Inui, 1989) . The foot structure has been
identified as the ryanodine receptor and shown to be the cal-
cium release channel of SR (Hymel et al., 1988; Inui et al .,
1987a, b; Lai et al., 1988 ; Smith et al ., 1988) . The calcium
release channel of SR represents a new class of intracellular
channels characterized their fourfold symmetry and large
size (260 x 260 x 1600 . Because the foot structure is in-
volved in junctional association and contains the machinery
for calcium release, it has been termed the junctional chan-
nelcomplex (JCC) (Wagenknecht et al., 1989). E-C coupling
has been postulated to involve an interaction between the di-
hydropyridine (DHP) receptor in the transverse tubule/plas-
malemma and the JCC (Rios and Brum, 1987).
1. Abbreviationsusedin thispaper: DHP, dihydropyridine; E-C, excitation-
contraction; JCC, junctional channel complex; LSM, low serum medium;
SR, sarcoplasmic reticulum.
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ulation ofboth the contractile protein genes (which have
been studied in detail previously) and the genes en-
coding the calcium channels involved in E-C coupling.
Induction of both calcium channels is accompanied by
profound changes in BC3H1 cell morphology including
the development of many components of mature skel-
etal muscle cells, despite lack of myoblast fusion. Visu-
alized by electron microscopy, the JCC appears as "foot
structures" located in the dyad junction between the
plasmalemma and the sarcoplasmic reticulum of the
BC3H1 cells. Development of foot structures is concomi-
tant with JCC mRNA expression. Expression of the
JCC and DHP receptor mRNAs and formation of the
foot structures are inhibited specifically by fibroblast
growth factor.
The JCCs have been purified from both skeletal and
cardiac muscle (Inui et al., 1987a, b; Lai et al ., 1988; Smith
et al., 1988) . The protomer size and primary structure are
available from cloning studies. Two isoforms of the JCC are
known, one from skeletal muscle and another from cardiac
muscle (Marks et al., 1989; Otsu et al., 1990; Takeshima et
al., 1989; Zorzato et al., 1990) . The JCC consists of a
tetramer (Saito et al., 1988) comprised of four identical
subunits each with a molecular weight of 565,000 (Marks et
al ., 1989; Otsu et al., 1990; Takeshima et al., 1989; Zorzato
et al., 1990). The DHP receptor is a heteropolymer com-
prised of five subunits. The a,-subunit of the skeletal mus-
cle DHP receptor has also been cloned and its primary struc-
ture determined (Tanabe et al., 1987). The essential role of
the a,-subunit has been convincingly demonstrated in that
transfection of this subunit restores E-C coupling in dysgenic
mouse cells (Tanabe et al., 1988).
Myogenic differentiation is associated with coordinate
regulation of the contractile proteins (Devlin and Emerson,
1978). The extent to which the genes encoding proteins re-
quired for E-C coupling (the JCC and DHP receptor) partici-
pate in this coordinate regulation has not been examined.
BC3H1, a nonfusing muscle cell line derived from a mouse
brain tumor (Schubert et al., 1974), has received consider-
able attention as a model for studying muscle cell differentia-
303tion and the regulation of muscle-related proteins. BC3Hl
cells can be induced to differentiate by removal of growth
factors from the culture medium or by allowing cultures to
reach confluence. Under these conditions, BC3H1 cells ex-
press many of the striated muscle contractile protein genes
(Munson et al., 1982; Olson et al., 1983 ; Taubman et al.,
1989), as well as smooth muscle a-actin (Strauch et al.,
1986) and the nicotinic acetylcholine (Olson et al., 1984)
and insulin receptors (Standaert et al., 1984). BC3H1 cells
also express the skeletal muscle-type voltage-gated calcium
channel (Caffrey et al., 1987) . In addition, we have recently
shown that the BC3H1 cells express the JCC (Marks et al.,
1989) .
In the present study we have examined growth factor regu-
lation oftheJCC, DHPreceptor, and muscle-specificmRNAs
in BC3H1 cells. Using electron microscopy we have demon-
strated a correlation between the expression ofthese muscle-
specific mRNAs and the appearance of foot structures and
other muscle-specific proteins, as well as changes in BC3H1
cell morphology which occur during reversible differentia-
tion in response to mitogen withdrawal and readdition.
Materials and Methods
Growth Factors
Mouse EGF (receptor grade), bovine FGF, and PDGF (50% pure) were
from Collaborative Research, Inc. (Bedford, MA). PDGF B chain homo-
dimer (recombinant c-sis product) was obtained from Amgen Biologicals,
Inc. (Thousand Oaks, CA).
cDNAProbes
The JCC probe used for all Northern blots, referred to as CRC 161 (Marks
etal., 1989), corresponds to nucleotides 8,465-8,996ofthe full-lengthJCC
(Takeshima et al., 1989). The skeletal muscle DHP receptor probe is a 2-kb
cDNA obtained by screening a rabbit skeletal muscle cDNA library (Marks
et al., 1989) with a 570-bp cDNA obtained by polymerase chain reaction
amplification of rabbit RNA using methodology essentially as described
previously (Marks et al., 1990) . This probe corresponds to nucleotides
2,500-4,500 ofthe previously described DHP receptor cDNA from rabbit
skeletal muscle (Tanabeet al., 1987). The actin probe is pAC 269 fromchick-
en skeletal muscle a-actin (Fornwald et al., 1982). This probe recognizes
both muscle specific (smooth, skeletal, and cardiac a-actins) and nonmus-
cle (ß and y) actin isoforms. The a-tropomyosin probe is a cDNA encoding
the entire coding region ofthe rat a-tropomyosin (Ruiz-Opazo et al., 1985;
Wieczorek et al., 1988). All probes were uniformly labeled with random
primers using Klenow and a p32 dCTP to a sp act of 109 cpm per pg. (The
actin and a-tropomyosin probes were generous gifts from Dr. Bernardo
Nadal-Ginard, Howard Hughes Medical Institute, Children's Hospital,
Boston, MA).
RNA PreparationandNorthern BlotAnalysis
RNA was prepared using standard guanidinium-isothiocyanate lysis buffer
andcentrifugationover a cesium chloride gradient. RNA was size separated
on formaldehyde/agarose gels and Northern blot transfer was carried out
overnightusing IOx SSC. Hybridization was at 42°C overnightandwashing
was at 55°C using 0.2x SSC. Films were autoradiographed with a single
intensifying screen at -70°C. Tb assure that equivalent amounts of RNA
were present in each lane, Northern blots were also hybridized with cDNA
encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from chick-
en muscle (data not shown). After autoradiography individual mRNA
bands were quantitated using a laser densitometer. The optical density of
each ofthebands was divided either by the GAPDH orcontrol sample band
optical density. Each data point presented in Fig. 8 represents data from at
least two and in most cases three separate experiments. Data are expressed
as mean values. The statistical significances ofdifferences in mean values
between mRNA levels for induced BC3H1 cells and samples from dein-
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ducedcells after treatmentwith growth factors wasassessed by theunpaired
Student nest. The P < 0.05 level was considered to be significant.
CellCultureandFixation
The BC3H1 mouse cell line (Schubert et al., 1974) was a gift from Dr. Eric
N. Olson (Department ofBiochemistry and Molecular Biology, University
of Texas, M.D. Anderson Hospital and Tumor Institute). Cultures were
grown on 10-cm tissue culture dishes in DME containing 20% FCS, 100
U/ml penicillin, and 100 pg1ml streptomycin as described (Olson et al.,
1983). The medium was changed every 2 d. To minimize differentiation of
BC3H1 and induction of contractile protein or JCC genes, cells were pas-
saged while no more than 75% confluent. To initiate differentiation,
medium containing 20% FCS was removed and replaced with low serum
medium (LSM) containing 0.5% FCS. Tb determine the effects of FGF on
the expressionofJCC feet structures" BC3H1 cells werecultured in growth
medium(20% FCS) at low confluence (-30%) and switched to either LSM
or LSM plus FGF (50 ng/mi). Samples were harvested after 3 and 5 d and
prepared for electron microscopy as described below, and fresh FGF was
added each day.
ElectronMicroscopy
Monolayers were washed three times with PBS at room temperature and
fixed for 15 min at room temperature in 2.5% glutaraldehyde, 1% tannic
acid (Electron microscopic grade; Polysciences, Inc., Warrington, PA) in
0.1 sodiumcacodylate,pH 7.2. Cells werethen scrapedwith a rubberpolice-
man and pelleted at 800 g for 5 min. Cells were resuspended in fresh gluta-
raldehyde-tannic acid cacodylate buffer, pH 7.2, and fixed for another 2 h
at 4°C. Cells were washed twice with 0.1 M sodium cacodylate, pH 7.2,
treated for 2 h at 4°C in 1% OsO4 in 0.1 M sodium cacodylate, pH 7.2, and
then washed twice with 0.1 M sodium cacodylate, pH 7.2 (Saito et al.,
1978). All samples were block stained with 0.5% uranyl acetate in veronal-
acetate buffer (pH 6.0) for 2 h at room temperature, dehydrated in a series
of increasing ethanol concentrations, then the ethanol was replaced with
propylene oxide, and the samples were embedded in Epon 812 (Electron
Microscopy Sciences, Fort Washington, PA). Thin sections were cut on an
LKB Ultratome (LKB Instruments, Inc., Rockville, MD), stained with 1%
uranyl acetate in 50% ethanol for 5 min, counterstained with lead citrate




BC3H1 cells, cultured in growth medium containing 20%
FCS, had a typical flat, round-edged morphology with small
processes extending from the cell as previously described
(Schubert et al. 1974). When the cells were subjected to
mitogen withdrawal (culturing in 0.5 % serum [LSM]), there
was a marked change in cell morphology. The cells became
more elongated and spindly shaped. Differentiation to this
"muscle phenotype" occurred within 3-5 d under these con-
ditions. In this cell line, muscle filaments do not become
oriented into striations typical of skeletal muscle and myo-
tubes do not form.
As viewed by electron microscopy, undifferentiated, pro-
liferating BC3H1 cells cultured in 20% FCS were devoid of
myofibrils and foot structures (Fig. 1). Upon differentiation
in LSM (Fig. 2) BC3H1 cells develop myofibrils as previ-
ously reported (Schubert et al ., 1974) . Unique to this study,
we observed the development of foot structures at day 2 .
These structures becameprominent by day 3 ofserum depri-
vation (Fig. 2). Both myofibrils and foot structures appeared
coordinately and were abundant by 5 d of culture in LSM
(Fig. 2) .
A feature of the BC3H1 cells is the ability to deinduceP
muscle-specific gene expression by readdition of growth fac-
304Figure 1. Undifferentiated proliferating BC3H1 cells in 20% FCS ; (a) A portion of the cell showing plasmalemma (PM), the nucleus (N),
and rich proliferation of microtubules (arrowheads) and actin (thin) filaments (arrows) . (b) Higher power showing the plasmalemma (PM)
and sarcoplasmic reticulum (SR) apposed by a -150-A gap but devoid of foot structures . (c) Surface of the cells with characteristic
microvilli (MV) . Microtubules (MT) can be seen in cross-section . (d) Enlarged section near the surface from c as indicated by asterisk.
The microvilli contain actin filaments (F ; arrowhead) .
tors to induced monolayers, orby replating cultures in growth
medium (Lathrop et al ., 1985 ; Munson et al ., 1982 ; Schu-
bert et al., 1974 ; Taubman et al ., 1989) . This phenomenon
ofreversibility was also observed for the JCC structure. Dif-
ferentiated cell cultures with the muscle phenotype were
trypsinized and replated in 20% FCS at low density (10%
confluence) . As shown in Figs . 3-5, replating resulted in a
progressive and ultimately complete loss of JCC and myo-
fibrils by day 5 (Fig . 5) .
Calcium ChannelmRNAAccumulation in
Differentiating BC3H1 Cells
To determine whether the induction and deinduction of the
JCC structure visualized by electron microscopy mirrored
the expression ofJCC mRNA, a time course ofJCC mRNA
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accumulation was performed (Fig . 6 A) . In subconfluent,
proliferating BC3H1 cells, grown inmedium containing20%
FCS, the JCC mRNA was not detected (Fig . 6 A, lane 1) .
JCC mRNA was detected 48 h after cells were switched to
LSM (Fig . 6 A, lane 3) . JCC mRNA levels continued to in-
crease up to 7 d (Fig. 6 A, lane 6) and was reversible . When
the fully induced cells were switched to growthmedium con-
taining 20% fetal calf serum, there was a rapid deinduction
of theJCC mRNA within 24 h (Fig. 6 A, lane 7) . This dein-
duction was also seen when the induced cells were replated
at low density and allowed to grow for 48 h in medium con-
taining20% FCS (Fig. 6A, lane 8) . The induction and dein-
duction of the DHP receptor occurred with a time course
similar to that seen for the JCC mRNA . (Fig . 6 B) .
It hasbeen previously shown that duringBC3H1 differenti-
ation themRNA encoding thenonmuscle actin isoform (ß-ac-
305Figure 2. BC3H1 cells 5 d after being placed in LSM (0.546 FCS) . (a) Muscle filaments showing myosinM bands (MB) can be observed
throughout a cross-section. (b) Foot structures are now clearly visible (arrowheads) in the junction between the plasma membrane (PM)
and apposed sarcoplasmic reticulum (SR), double arrows indicate the trapezoidal appearance of the foot structure. (c) Higher magnification
of a section from a (asterisk) showing myosin M bands connected via bridges in a hexagonal array (arrows) .
tin) is deinduced and the muscle-specific form (ca-actin)
accumulates (Strauch et al ., 1986) . We compared the time
course for the actin isoform switch in BC3H1 cells with
that observed for the induction and deinduction of the JCC
mRNA . The time course for the actin isoform switch is
shown in Fig . 6 C . In subconfluent, proliferating cells (Fig.
6 C, lanes 1-3), 0-actin (upper band) was the predominant
form, but after 72 h ofincubation in LSM (lane 4), there was
a switch in actin isoforms, with a-actin (lower band) pre-
dominating over 0-actin . While the probe used in this study
cannot distinguish between thethree a-actin isoforms, previ-
ous studies (Taubman et al., 1989) have shown that the
smooth, cardiac, and skeletal muscle a-actin isoforms are all
induced by this protocol . The switch from 0-actin to ce-actin
was also reversed by addition of20% fetal calf serum to the
culture medium (Fig . 6 C, lane 7) or by replating cells at low
density in growth medium (lane 8) .
One ofthe earliest changes in contractile protein gene ex-
pression in BC3H1 cells is the switch from the nonmuscle
to the skeletal muscle isoform of a-tropomyosin (Taubman
et al ., 1989) . We therefore compared the expression ofJCC
mRNA with that of a-tropomyosin . As shown in Fig . 6 D
(lanes 1-6), the time course for the switch from the nonmus-
cle (upper band) to the skeletal muscle (lower band) iso-
formsofa-tropomyosinwas similarto that seen for the induc-
tion and deinduction of the JCC and DHP receptor mRNAs
(Fig . 6, A and B) and occurred concomitantly with the iso-
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form switch observed for actin (Fig . 6 C) . The isoform
switch for a-tropomyosin was also reversed by addition of
20% fetal calf serum to the culture medium (Fig . 6 C, lane
7) or by replating cells at low density in growth medium
(lane 8) .
Effects ofGrowth Factors on Calcium
Channel Expression
It has been previously reported that either FGF or EGF can
reverse the induction of some of the muscle specific genes
in BC3H1 cells (Clegg et al ., 1987 ; Lathrop et al ., 1985 ;
Vaidya et al ., 1989 ; Wice et al ., 1987) . To determine
whether the JCC mRNA was also responsive to these fac-
tors,BC3H1 cells were induced to differentiateby a 3-d incu-
bation inLSM and then treated for either 1 or 3 d with EGF
(300 ng/ml, Fig . 7 A, lanes 2 and 3) ; FGF (50 ng/ml, Fig .
7 A, lanes 4 and 5) ; or PDGF (5 half-maximal units, Fig. 7
A, lanes 6 and 7) . As shown in Fig . 7 A, only FGF treat-
ment for 3 d (Fig . 7 A, lane 5) caused deinduction of the
JCC mRNA .
In addition to the JCC, the regulation of the expression of
the skeletal muscle isoform oftheDHP receptor was also ex-
amined . As shown in Fig. 7 B, lane 5, mRNA encoding the
skeletal isoform of the DHP receptor was also downregu-
lated specifically by FGF.
In contrastto theJCC and the DHP receptor, ca-tropomyo-
306Figure 3 Replating of differentiated BC3H1 cells in 20% FCS-containing medium . After 1 d, two populations of cells are observed in
a and b vs. c and d. (a) Cell that is devoid of myofibrils . (b) Foot structures are not detected between plasmalemma (PM) and apposed
sarcoplasmic reticulum (SR) . (c) Cell that retains some myofibrils (MF) . (d) Foot structures are observed between plasmalemma (PM)
and sarcoplasmic reticulum (arrowheads) .
sin mRNA accumulation was not altered by FGF in BC3H1
cells under identical conditions. As shown in Fig . 7 C, lane
5, even after 72 h ofFGF treatment, high levels of the skele-
tal isofotm of a-tropomyosin persisted without induction of
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the nonmuscle isoform . This is in contrast to the results
shown in Fig . 6 D, where the nonmuscle isoform of a-tropo-
myosin was "reinduced" within 48 h of replating BC3H1 at
low density in growth medium . Fig. 8 summarizes the data
307Figure 4. 3 d after replating of differentiated BC3H1 cells in 20% FCS containing medium . Two populations are observed a and b vs .
c and d. (a) Elongate cells with ruffled surface are devoid of muscle characteristics . (b) Surface membrane and SR are devoid of JCC .
(c) Rounded cells with smooth surface plasma membrane retaining myofibrils . (d) Surface membrane and apposed SR . Most of the JCC
are gone although there is the suggestion of remaining JCC (arrowheads) .
on the effects of growth factors on the expression ofthe JCC
and DHP receptor genes and the contractile protein genes in
BC3H1 cells . Comparison of Fig . 8, A-C demonstrates the
coordinate regulation of the JCC and DHP receptor genes
and the genes encoding a-tropomyosin and a-actin . Fig . 8,
A andB also demonstrate the downregulation ofthe JCC and
DHP receptor genes by 20% FCS and specifically by FGF,
but not by EGF or PDGF.
FGFBlocks the FormationofFoot Structures
We also examined the effects ofFGF on the formation of foot
structures induced by withdrawal of growth medium .
Undifferentiated BC3H1 cells (grown in 20% FCS) were
switched to LSM or LSM plus FGF (50 ng/ml) . After 3 and
5 d, cells were fixed and stained for electron microscopy. Af-
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ter 3 d cells cultured in LSM alone had well defined foot
structures and by 5 d these cells appeared as shown in Fig .
2 . However, treatment with FGF blocked the formation of
foot structures at both 3 and 5 d (data not shown) while these
same cells did exhibit other features of differentiation includ-
ing myofibrils .
Discussion
The terminal cisternae of the SR, containing the JCC, and
the transverse tubule containing the DHP receptor are ap-
posed to one another in the triad junction of skeletal muscle .
Both molecules are essential to calcium signalling and re-
lease processes and consequently to contraction in striated
muscle (Fleischer and Inui, 1989 ; Tanabe et al ., 1988) . Dur-
308FigureS 5d after replating ofdifferentiated BC3H1 cells into 20 % FCS containing medium . (a) These cells are devoid of muscle filaments
and JCC (see c) . (b) Section close to the surface showing microvilli (MV) . (c) TheJCC is no longer observable between the plasmalemma
and the SR .
ing E-C coupling, depolarization of the transverse tubule
results in activation of the JCC with the subsequent release
ofintracellular calcium from stores within theSR . The avail-
ability of cDNA clones encoding the 16-kb mRNA of the
JCC (Marks et al ., 1989) and the skeletal isoform of the
DHP receptor has made it possible to study the regulation
of calcium channel gene expression . This study is the first
to use these probes to correlate the induction/deinduction of
the mRNA encoding the calcium channels involved in E-C
coupling with the formation of the foot structure at the triad
junction during muscle cell differentiation .
The present study demonstrates a correlation between the
expression of key receptors involved in E-C coupling (JCC
and DHP receptor), the contractile protein genes and pro-
found changes in cell morphology. We find that FGF, but not
EGF or PDGF, regulates the expression of the calcium han-
dling genes . More interestingly, addition ofFGF also blocks
the formation offoot structures in cells induced to differenti-
ate by serum withdrawal, while other elements of differen-
tiated muscle cells are expressed (including myofibrils) .
Thus, inhibition of the formation of the foot structures re-
quired for excitation-contraction coupling appears to be an
important effect of FGF in BC3H1 cells .
Changes in cellular morphology in response to growth fac-
tor withdrawal were examined using electron microscopy
(Figs . 1-5) . In the undifferentiated BC3H1 cells, the SR and
plasmalemma are associated, although foot structures are
not visualized . 2 d after growth factor withdrawal, myofibrils
appear and the beginnings of foot structures are also appar-
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ent . By 5 d, the BC3H1 cells have well-developed muscle
filaments and the SR is associated with the plasmalemma via
foot structures spanning the gap . The foot structure in the
junction of the BC3H1 cells is characteristic in appearance
of that associated with the terminal cisternae of the SR in the
triad junction of skeletal muscle (Salto et al., 1988) . In the
case of the JCC, the protomer is targeted to the junctional
facemembrane of the SR, associates to form a foot structure,
and then associates with the plasmalemma in a manner sug-
gesting the ability to be functionally coupled .
In response to serum withdrawal, both the induction of
foot structures (Figs . 1-5), and the JCC and DHP receptor
mRNAs (Fig . 6, A and B, lane 3) occur within 48 h in pro-
liferating BC3H1 cells . Deinduction of the foot structure
(Figs . 3-5) and the JCC and DHP receptor mRNAs (Fig . 6,
A, lanes 7 and 8) occur within 2 d . This rapid turnover of
the 16-kb JCC and 7.5-kb DHP receptor mRNAs and the
JCC protein with a molecular mass of 2.3 million indicates
that the JCC gene and protein and the DHP receptor gene
are highly regulated in vitro . Moreover, the regulation is co-
ordinate with that of the contractile protein genes and the
DHP receptor.
FGF has been observed to inhibit skeletal muscle differen-
tiation (Clegg et al ., 1987 ; Lathrop et al ., 1985 ; Wice et al .,
1987) . We have found thatFGF deinduces both the JCC and
DHP receptor (Figs. 7 and 8,A and B) . Under the same con-
ditions, FGF has no detectable effect on the expression of
et-tropomyosin (Figs . 7 and 8 C) . The mRNAs encoding the
skeletal muscle myosin light chains 1 and 3 and troponin T
309Figure 6. Northern blotanalyses showing the time course for induc-
tion and deinduction of muscle-specific mRNAs in BC3H1 cells
(See Materials and Methods for description of the cDNA probes
used) : (A) ryanodine receptor/JCC ; (B) DHP receptor ; (C) actin ;
and (D) a-tropomyosin . 110111 cells were cultured in growth
medium (20% FCS) until 50% confluent (lane 1) and then were
switched toLSM (0.5% FCS) . Cells were maintained in LSM for
1 (lane 2), 2 (lane 3), 3 (lane 4) ; 4 (lane 5) ; and 7 d (lane 6) . At
day 7 the cells were switched to growth medium (20% FCS) and
samples were harvested at 24 h (lane 7), or replated at low density
and harvested after 48 h, (lane 8) . The upper band inC represents
0-actin mRNA, the lower band, a-actin . The upper band in D
represents the nonmuscle a-tropomyosin isoformmRNA, the lower
band, the muscle-specific isoform of a-tropomyosin mRNA .
are likewise unresponsive to FGF (data not shown) . This
suggests that in BC3H1 cells the effects ofFGF on myogene-
sis are coordinate with blockade of calcium channel expres-
sion and may be distinct from its effects on muscle-specific
gene expression . Alternatively the half-life of the muscle-
specific contractile protein mRNAs may be significantly
longer than those of the calcium channels and that the time
points sampled (1 and 3 d after growth factor treatment) are
too early to see an effect on the contractile protein gene ex-
pression .
The mechanism ofFGF blockade of myogenic differentia-
tion requires further study. Growth-stimulating hormones
which involve tyrosine kinases and allow cells to pass from
Ga to G, are associated with an increase in c-myc levels
(Coughlin et al ., 1985) . FGF transiently increases c-myc lev-
els in BC3H1 but constitutive expression of c-myc does not
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Figure 7 . Northern blot analyses showing thedeinduction of (A) the
ryanodine receptor/JCC, (B) DHP receptor, and (C) a-tropomyo-
sin mRNAs in 110111 cells by growth factor. Lane 1, induced cul-
tures (grown in LSM for 3 d) ; lanes 2 and 3, duplicate cultures
treated with 300 ng/ml EGF for 1 and 3 d, respectively ; lanes 4
and 5, duplicate cultures treated with 50 ng/ml FGF for 1 and 3 d,
respectively ; lanes 6 and 7, duplicate cultures treated with PDGF
(5 half-maximal units of50% humanPDGF) for 1 and 3 d, respec-
tively. Similar results to those in lanes 6 and 7 were obtained with
20 ng/ml recombinant PDGF B-chain homodimer. These results
are representative of three separate experiments .
fully block muscle cell differentiation (Schneider et al .,
1987) . Constitutive expression of the muscle-specific factor
MyoD1 cDNA is unable to block the inhibiting effects of
FGF on myogenic differentiation (Konieczny et al., 1989) .
However, MyoD1 constitutively expressed in the presence
of the related muscle-specific factor myogenin promotes
differentiation and fusion in BC3H1 cells (Brennan et al .,
1990) . Thus MyoDI and myogenin appear to function coop-
eratively to regulate myogenesis (Vaidya et al ., 1989) . The
mechanism of FGF inhibition of muscle cell differentiation
thus appears to be multifactorial .
Our data also suggests that FGF's effects on myogenic
differentiation are multifactorial and involve regulation spe-
cifically of the formation of foot structures, and the calcium
handling genes, in addition to direct effects on the muscle-
specific factors myogenin and MyoDl . In the rat myogenic
cell line L6E9-B, translation of muscle-specific genes is cal-
cium dependent (Endo and Nadal-Ginard, 1987) . The effect
of FGF on the calcium-handling genes may alter intracel-
lular calcium concentrations and such changes in calcium
might act as signals for subsequent events controlling cellu-
lar differentiation . Thus, in addition to directly regulating
transcriptional events leading to myogenic differentiation,
another role for FGF may include indirect regulation of
muscle-specific mRNA translation via its effects on regula-
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Figure 8. Effects of growth fac-
tors on JCC and DHP receptor
gene expression in differentiated
BC3H1 cells. BC3H1 cells were
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FCS) until 50% confluent and
thenwereswitched to LSM (0.5%
FCS) at day 0. Cells were main-
tained in LSM for 7 d. At day 7
(arrow) cells were switched either
to growth medium (20% FCS) or
to LSM plusgrowth factors (EGF,
FGF, or PDGF as indicated). For
both a-tropomyosin and a-actin
no decrease in mRNA levels was
seen with addition of any of the
growth factors (data not shown).
Each data point represents at least
two and in most cases three sep-
arate experiments. Deinduction
of the JCC, and DHP receptor
mRNA levels, compared to fully
inducedlevels(atday7afterswitch-
ing to LSM), by either 20% FCS
or FGF, was significant at P <
0.05 level.
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